Upon conclusion of this program, participants should be able to:

• Recognize the role of minimally invasive surgery in lung and esophageal cancer
• Understand molecular testing options for lung cancer
• Describe the impact of new radiation techniques in curative and palliative treatment of lung and esophageal cancer
• Evaluate eligibility of lung cancer patients for targeted therapies

Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.